Garching / Munich, Germany, November 13, 2025 – (ITM), a leading radiopharmaceutical biotech company, today announced that the U.S. Food and Drug Administration (FDA) completed its filing review and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback